Expertise in
4
conditions

Awa K. Traore

Secondary Rte, 
Bamako, BKO, ML 
Expertise in
4
conditions
Secondary Rte, 
Bamako, BKO, ML 
OverviewLocationsClinical Research

Overview

Awa Traore practices in Bamako, Mali. Ms. Traore is highly rated in 4 conditions, according to our data. Her top areas of expertise are Diarrhea, Secondary Peritonitis, Peritonitis, Colostomy, and Ileostomy.

Her clinical research consists of co-authoring 88 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Secondary Rte, Bamako, BKO, Mali

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Biological
Study Phase: Phase 2
Phase 3, Observer-blind, Randomized, Active Controlled Trial to Assess the Safety of an Investigational Meningococcal Serogroups ACYWX Conjugate Vaccine (NmCV-5) and Compare Its Immunogenicity to a Licensed Meningococcal Serogroups ACYW Conjugate Vaccine (Menactra®), in Healthy Subjects 2 to 29 Years of Age
Phase 3, Observer-blind, Randomized, Active Controlled Trial to Assess the Safety of an Investigational Meningococcal Serogroups ACYWX Conjugate Vaccine (NmCV-5) and Compare Its Immunogenicity to a Licensed Meningococcal Serogroups ACYW Conjugate Vaccine (Menactra®), in Healthy Subjects 2 to 29 Years of Age
Enrollment Status: Completed
Publish Date: July 27, 2021
Intervention Type: Biological
Study Drugs: NmCV-5, Menactra
Study Phase: Phase 3
View 1 Less Clinical Trial

82 Total Publications

Breast Cancer In Women: Prognostic Factors And Survival In The General Surgery Department At The Gabriel Touré University Hospital, Bamako
Breast Cancer In Women: Prognostic Factors And Survival In The General Surgery Department At The Gabriel Touré University Hospital, Bamako
Journal: Le Mali medical
Published: November 25, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Traore's expertise for a condition
ConditionClose
      View All 33 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile